Activity value 75china Buyer&Supplier,Last transaction date:
2026-02-25
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for dijia pharmaceutical group co ltd from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 15 transactions, with a transaction quantity of 25323.5 and a transaction weight of 0.
YearTransactionsQuantityWeight
20258393635.99196.2
20261525323.50
Bill of lading data
<
1/15
>
Trade date
2026/02/25
B/L No.
——
Suppliers
dijia pharmaceutical group co ltd
Buyers
ms rotex pharma
POLs
——
PODs
ipaf
Supply area
China
Purchas area
Pakistan
Weight
——
Amount
2963.58
Hs code
29359090
Product tags
bat,expiry date,turing,celecoxib,pharmaceutical raw material,oct
Suppliers
dijia pharmaceutical group co ltd
Buyers
masfa industries
POLs
——
PODs
lpaf
Supply area
China
Purchas area
Pakistan
Weight
——
Amount
4343.18
Hs code
29242990
Product tags
itopride,bat,chi,ipm,pharm,powder form,pharmaceutical raw material,bran
Product description
PHARMACEUTICAL RAW MATERIAL ......NAME: ITOPRIDE HCL....IN POWDER FORM......BATCH NO:-BL250503........MFG DATE:.04.05.2025 EXP DATE:04.2029...QTY: 100KGS..........BRAND:DIJIA PHARMA....I/O AND SHIPMENT......CHINA....
Expand
Trade date
2026/02/09
B/L No.
107973277050
Suppliers
dijia pharmaceutical group co ltd
Buyers
công ty cổ phần dược phẩm hà tây
POLs
——
PODs
——
Supply area
Other
Purchas area
Vietnam
Weight
——
Amount
6510
Hs code
29183000
Product tags
carboxylic acids with aldehyde
Product description
Nguyên liệu dùng sản xuất thuốc LOXOPROFEN SODIUM HYDRATE TC: JP XVIII, Số Lô: LS250910A. NSX: 09/2025. HSD:09/2028. Nhà sx: DIJIA PHARMACEUTICAL GROUP CO.,LTD.CHINA
Expand
Trade date
2026/02/06
B/L No.
107968222940
Suppliers
dijia pharmaceutical group co ltd
Buyers
công ty cổ phần dược phẩm wealphar
Product description
Nguyên liệu sản xuất thuốc Glipizide; tiêu chuẩn EP11; mới 100%; số lô: GL251171F; ngày sx: 07/11/2025; hạn sử dụng: 10/2029; nhà sx: Dijia Pharmaceutical Group Co., Ltd.
Expand
Trade date
2026/01/30
B/L No.
107940924560
Suppliers
dijia pharmaceutical group co ltd
Buyers
công ty cổ phần hóa chất global hub
POLs
——
PODs
——
Supply area
Other
Purchas area
Vietnam
Weight
——
Amount
2750
Hs code
29183000
Product tags
carboxylic acids with aldehyde
Product description
Nguyên liệu sản xuất thuốc ( dược chất): LOXOPROFEN SODIUM HYDRATE. Tiêu chuẩn: JP 18. Số lô: LS250801C, nsx: 27.08.2025, hsd: 07.2027, dạng bột, 25kg/drum. Mới 100%
Expand
Trade date
2026/01/23
B/L No.
107920926260
Suppliers
dijia pharmaceutical group co ltd
Buyers
công ty cổ phần dược phẩm tv pharm
Product description
Dược chất là NLSX Thuốc: Flunarizin (dưới dạng Flunarizin dihydroclorid) (Current EP = EP 11.2), NSX: Dijia Pharmaceutical Group Co.,Ltd. Số lô: FL250593F (Date (05/2025 _ 04/2027)
Expand
Trade date
2026/01/17
B/L No.
7521265
Suppliers
dijia pharmaceutical group co ltd
Buyers
verdant life sciences pvt ltd.
Product description
Nguyên liệu thuốc dùng Nghiên cứu, Kiểm nghiệm: Solifenacin Succinate, TC:EP11.0. Số Lô:SL250602F. NSX:06/2025. HSD; 06/2028. Nhà SX: DIJIA PHARMACEUTICAL GROUP CO.,LTD
Expand
Trade date
2026/01/05
B/L No.
——
Suppliers
dijia pharmaceutical group co ltd
Buyers
m.s.pacific pharmaceuticals ltd.
Product description
PHARMACEUTICAL ALLOPATHIC RAW MATERIAL (FLAVOXATE HCL )........BATCH NO:FH251103' FH251104........MFG DATE 15/11/2025: 16/11/2025.......EXP DATE 01/10/X2D0y227j.H.A.r.d.f.a.iN5EAT WEIGHT 200 KG
Expand
Trade date
2025/12/29
B/L No.
——
Suppliers
dijia pharmaceutical group co ltd
Buyers
aspin pharma pvt ltd.
POLs
——
PODs
kpaf
Supply area
China
Purchas area
Pakistan
Weight
——
Amount
210.51
Hs code
29335990
Product tags
pharmaceutical raw material,flunarizine dihydrochloride
Product description
PHARMACEUTICAL RAW MATERIAL FLUNARIZINE DIHYDROCHLORIDE
Expand
dijia pharmaceutical group co ltd is china Buyer&Supplier,
and primarily engages in the import and export business of products such as methyl,propy,benzimidazole.
According to the 52wmb.com global trade database, as of 2026-02-25, the company has completed 209 international trades,
with its main trading regions covering india,pakistan,vietnam etc.
The core products include HS29339990,HS29332990,HS29349990 etc,
and its main trading partners are dhanuka laboratories ltd.,verdant life sciences pvt ltd.,sharika life science ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on dijia pharmaceutical group co ltd is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.